L Schneidewind1, J Kranz2, K Boehm3, P Spachmann4, F Siegel5, N Huck5, H M Fritsche4. 1. Klinik für Urologie, Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Straße, 17475, Greifswald, Deutschland. laila.schneidewind@uni-greifswald.de. 2. St.-Antonius Hospital, Klinik für Urologie und Kinderurologie, Akademisches Lehrkrankenhaus der RWTH Aachen, Dechant-Deckers-Straße 8, 52249, Eschweiler, Deutschland. jennifer.kranz@sah-eschweiler.de. 3. Martini-Klinik, Prostatakrebszentrum, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Deutschland. 4. Klinik für Urologie, Universität Regensburg, Caritas Krankenhaus St. Josef, Regensburg, Deutschland. 5. Klinik für Urologie, Universitätsmedizin Mannheim, Mannheim, Deutschland.
Abstract
BACKGROUND: Infectious diseases caused by multi-resistant pathogens are increasing worldwide and are posing a challenge to German urology as well. Furthermore, there is a limited perspective of new antibiotic developments. One way out of this dilemma is a differentiated handling and use of antibiotics (antibiotic stewardship, ABS). AIM: The aim of this review is to identify key issues in modern urological antibiotic therapy, which can be considered as exemplary for the whole topic of ABS. This includes a review of the current data of the individual topics, including thought-provoking impulse for future clinical application and research. MATERIAL AND METHODS: The research group "infectious diseases" of GeSRU Academics identified the following central topics: excessive use of fluoroquinolones, diagnosis and treatment of urethritis and perioperative antibiotic prophylaxis. Subsequently, we performed a literature research in MEDLINE to uncover controversies and open questions of the individual topics within the meaning of ABS. RESULTS: The analysis of modern antibiotic therapy in urology shows numerous open questions in all quality dimensions of ABS: structural quality (e.g. through improved training of medical staff in the differentiated use of antibiotics), process quality (e.g. by improved adherence to existing infectiological guidelines, here in particular the perioperative prophylaxis and therapy of urethritis) and outcome (e.g. by detection of resistance rates and infection rates). DISCUSSION: The overarching and common goal is to avoid a post-antibiotic era. ABS programmes and a 10-point plan of the federal government are considered positive political developments in this area but do not release the individual urologist from a personal responsibility as part of his daily routine. A critical analysis of the topic "antibiotic treatment" is essential.
BACKGROUND:Infectious diseases caused by multi-resistant pathogens are increasing worldwide and are posing a challenge to German urology as well. Furthermore, there is a limited perspective of new antibiotic developments. One way out of this dilemma is a differentiated handling and use of antibiotics (antibiotic stewardship, ABS). AIM: The aim of this review is to identify key issues in modern urological antibiotic therapy, which can be considered as exemplary for the whole topic of ABS. This includes a review of the current data of the individual topics, including thought-provoking impulse for future clinical application and research. MATERIAL AND METHODS: The research group "infectious diseases" of GeSRU Academics identified the following central topics: excessive use of fluoroquinolones, diagnosis and treatment of urethritis and perioperative antibiotic prophylaxis. Subsequently, we performed a literature research in MEDLINE to uncover controversies and open questions of the individual topics within the meaning of ABS. RESULTS: The analysis of modern antibiotic therapy in urology shows numerous open questions in all quality dimensions of ABS: structural quality (e.g. through improved training of medical staff in the differentiated use of antibiotics), process quality (e.g. by improved adherence to existing infectiological guidelines, here in particular the perioperative prophylaxis and therapy of urethritis) and outcome (e.g. by detection of resistance rates and infection rates). DISCUSSION: The overarching and common goal is to avoid a post-antibiotic era. ABS programmes and a 10-point plan of the federal government are considered positive political developments in this area but do not release the individual urologist from a personal responsibility as part of his daily routine. A critical analysis of the topic "antibiotic treatment" is essential.
Authors: Tommaso Cai; Paolo Verze; Anna Brugnolli; Daniele Tiscione; Lorenzo Giuseppe Luciani; Cristina Eccher; Paolo Lanzafame; Gianni Malossini; Florian M E Wagenlehner; Vincenzo Mirone; Truls E Bjerklund Johansen; Robert Pickard; Riccardo Bartoletti Journal: Eur Urol Date: 2015-05-20 Impact factor: 20.096
Authors: Antonella Agodi; Annalisa Quattrocchi; Martina Barchitta; Veronica Adornetto; Aldo Cocuzza; Rosalia Latino; Giovanni Li Destri; Antonio Di Cataldo Journal: Int Surg Date: 2015-03
Authors: Florian M E Wagenlehner; Edgar van Oostrum; Peter Tenke; Zafer Tandogdu; Mete Çek; Magnus Grabe; Björn Wullt; Robert Pickard; Kurt G Naber; Adrian Pilatz; Wolfgang Weidner; Truls E Bjerklund-Johansen Journal: Eur Urol Date: 2012-06-12 Impact factor: 20.096
Authors: Matthew Mossanen; Joshua K Calvert; Sarah K Holt; Andrew C James; Jonathan L Wright; Jonathan D Harper; John N Krieger; John L Gore Journal: J Urol Date: 2014-09-06 Impact factor: 7.450
Authors: Zafer Tandogdu; Mete Cek; Florian Wagenlehner; Kurt Naber; Peter Tenke; Edgar van Ostrum; Truls Bjerklund Johansen Journal: World J Urol Date: 2013-08-24 Impact factor: 4.226